Neurology Market Research Reports & Industry Analysis

The notion “neurology” refers to a branch of medical scientific study dealing with central, peripheral and autonomic nervous systems, and their structure, functions and disorders, in particular. Companies involved in the neurology market produce a wide range of neurology devices. Neurology devices represent the largest and the most promising segments of the medical devices market.

In late 2016, the worldwide neurology devices market is expected to be over USD 7 billion. The largest neurology devices market is the USA, followed by Japan. Boston Scientific Corporation, DePuy Inc., CareFusion Corporation, Accuracy Inc. are amid major industry participants.

Research reports available in the Catalogue include data on the neurology devices market. The reports provide the profiles of the key vendors in the market space; analyses of trends factors affecting the market and forces contributing to the industry growth. The research studies evaluate the competitive landscape and future industry projections.

Found 22 publications
Neurology Devices Market Analysis By Product (Neurostimulation, Interventional Neurology, CSF Management, Spinal Cord Stimulation, Deep Brain Stimulation, Embolization, Neurovascular... US$ 4,950.00

... development of minimally invasive neurological and faster acting stimulation devices that attract higher market usage and penetration in the neurology devices market. Neurosurgery segment including ultrasonic ... for the expected growth of market in this region over the forecast period. Key participants of the neurology devices market include Johnson and Johnson, B.Braun ...

Aug, 2014 87 pages
Global Interventional Neurology Market Outlook to 2020 US$ 1,500.00

... such popular technique is interventional neurology. This technique provides a cost effective alternative for traditional neurosurgery. According to RNCOS new release, “Global Interventional Neurology Market Outlook to 2020”, the industry is expanding at a fast pace. The study has been done comprehensively including factors affecting growth, latest innovations, market ...

Jan, 2016 48 pages
Japanese Marktet for Neurovascular Devices US$ 6,995.00

... at nearly $553 million. The Japanese market for neurological devices includes bare platinum coils, coated coils, liquid embolics, neurovascular stents, ... in this market will be driven by the rapidly growing aging population in Japan and the increased demand and acceptance of endovascular cerebral aneurysm ...

Nov, 2013 76 pages
Chinese Market for Neurological Devices US$ 6,995.00

... was valued at over $528 million. The Chinese market for neurological devices includes fixed pressure CSF shunts, adjustable pressure CSF ... -based stereotactic systems, frameless stereotactic systems and aneurysm clips. Market growth will be driven by the continued acceptance of aneurysm treatment procedures, ...

Nov, 2013 242 pages
Physician Views: Sanofi secures EU approval for its multiple sclerosis treatment Lemtrada – how will neurologists use it? US$ 695.00

... Sanofi securing European approval for its multiple sclerosis ... therapies (Gilenya, Aubagio and Tecfidera – yet to launch in Europe) providing comparable efficacy with greater convenience, there is ... patients using the drug developing PML. This week's Physician Views poll will ask neurologists based in the 5EU ( ...

Sep, 2013
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU US$ 695.00

... collectively as the ABCRs), which for many years were positioned as the gold standard therapies of choice - see Physician Views Poll Results – Neurologists ... analysts, which Novartis and Sanofi will no doubt do their best to rectify. Analysts at Barclays recently noted that 'importantly, the multiple sclerosis ...

Sep, 2013
The Top 50 Neurodevice Companies Worldwide US$ 464.00

... , Number of Employees, Turnover and Foreign Trade. Report Target Market: 1) Neurodevice Companies Usage: competitive/financial analysis and strategic partner/alliance ... your business. Learn more about your target markets and target companies Top level research on all the major players in a market See ...

May, 2012 97 pages
The Top 30 Neurology Contract Research Organisations In Western Europe US$ 280.00

... 's Disease and Multiple Sclerosis. They are located right across Europe, from Belgium and the Netherlands to Sweden and Denmark. Profile ... , Biotechnology and Medical Device Associations The Top 30 Neurology Contract Research Organisations In Western Europe is a useful reference tool for CRO, pharmaceutical, ...

Aug, 2013 91 pages
Global Neurovascular Market: Trends & Opportunities (2013-18) US$ 800.00

... neurovascular industry. The major companies operating in this market include Stryker, Medtronic, Covidien (Ev3) and Johnson & Johnson (Micrus). The report titled “Global Neurovascular Market: Trends & Opportunities (2013-18)” provides a detailed insight into the neurovascular market. The report analyzes the primary segments of neurovascular disorders and the ...

Jul, 2013 46 pages
Indian Neurological Devices Market US$ 5,995.00

In 2012, the Indian market for neurological devices was valued at $13.5 million. The Indian market for neurological devices includes detachable coils, liquid embolics, neurovascular stents, neurovascular catheters, neurovascular guidewires, neuromodulation systems, neuroendoscopes, stereotactic systems and ...

Aug, 2013 236 pages
Neurostimulation Devices Market, 2012-2017 US$ 1,699.00

... continue to be the largest segment in the neurostimulation devices market over the forecast period (2012 to 2017). 3. Deep Brain Stimulation (DBS) segment ... companies. It also contains a SWOT analysis and detailed profile of leading devices within this segment. We have looked at both the existing commercial ...

Nov, 2012 124 pages
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016 US$ 2,000.00

... Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pituitary ACTH Hypersecretion (Cushing Disease ...

Jun, 2016 79 pages
Essential Tremor - Pipeline Review, H1 2016 US$ 2,000.00

Essential Tremor - Pipeline Review, H1 2016 SUMMARY Global Markets Direct’s, ‘Essential Tremor - Pipeline Review, H1 2016’, provides an overview of the Essential Tremor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Essential Tremor ...

May, 2016 49 pages
Global Neurostimulation Devices Market 2015 US$ 2,500.00 US$ 2,250.00

... market can be segmented into the following: SCS systems, DBS systems, SNS systems, VNS systems, and others. Technavio's report, Global Neurostimulation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts ...

Jun, 2015 83 pages
Intraoperative Neuromonitoring Market in the US 2016-2020 US$ 2,500.00 US$ 2,250.00

... driving the intraoperative neuromonitoring market in the US What are the key market trends impacting the growth of the intraoperative neuromonitoring market in the US What are the challenges to market growth Who are the key vendors in the intraoperative neuromonitoring market in the US What are the market opportunities ...

Nov, 2015 94 pages
European Neurological Device Markets US$ 8,995.00

In 2011, the total European market for neurological devices was valued at €628.3 million. Market growth will be driven by the continued acceptance of ... hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that ...

Mar, 2013 410 pages
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2023 US$ 3,995.00 US$ 3,196.00

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2023 Summary AD is an irreversible, neurodegenerative brain disease of the elderly, which leads to a progressive decline in memory and cognitive ... to 108.41 million cases in 2013 at a decadal growth rate of 31.80%. Scope The Alzheimer’s disease (AD) EpiCast Report provides an overview of the risk factors and global trends of AD in the ...

Mar, 2015 82 pages
Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product (Carotid Stent, Flow Diversion,... US$ 5,650.00

... prices of interventional neurology devices in Asia-Pacific. The global neurovascular devices/interventional neurology market is moderately competitive, with various global as well as local players. In 2014, the global neurovascular devices/interventional neurology devices market was dominated ...

Oct, 2015 166 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2015 US$ 2,000.00 US$ 1,600.00

... Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2015’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing's Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing ...

Sep, 2015 79 pages
European Markets for Neurological Devices 2010 (15 Countries) US$ 11,495.00

... devices. This market includes: Cerebrospinal fluid (CSF) shunts CSF drainage systems Detachable coils Liquid embolics Neurovascular catheters Neurovascular guidewires Neurovascular stents Spinal cord stimulators Vagus nerve stimulators Deep brain stimulators Sacral nerve stimulators ...

Jun, 2010 369 pages
European Markets for Neurological Devices 2010 (15 Countries) (Executive Summary) US$ 195.00

In 2009, the European market for neurological devices was valued at almost €500 million. This report covers Austria, Benelux, France, Germany, Italy, ... as Boston Scientific, Carl Zeiss, Codman, Medtronic and St. Jude lead the market, among many others. This report provides a comprehensive and detailed analysis ...

Jun, 2010 12 pages
U.S. Market for Neurological Devices US$ 5,995.00

In 2011, the U.S. neurological device market was valued at over $2.7 billion. This market encompasses CSF shunts, CSF external drainage systems, intracranial pressure ... and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The ...

Mar, 2013 396 pages
Skip to top